Intracranial arterial stenosis and recurrence in stroke patients with different risk stratifications by Essen stroke risk score

References

• von Weitzel-Mudersbach P, Andersen G, Hundborg HH, et al. Transient ischemic attack and minor stroke are the most common manifestations of acute cerebrovascular disease: a prospective, population-based study – the Aarhus TIA study. Neuroepidemiology. 2013;40(1):50–55. doi: 10.1159/000341696
   PubMed Web of Science ®Google Scholar
• Johnston SC, Gress DR, Browner WS, et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284(22):2901–2906. doi: 10.1001/jama.284.22.2901
   PubMed Web of Science ®Google Scholar
• Lovett JK, Dennis MS, Sandercock PA, et al. Very early risk of stroke after a first transient ischemic attack. Stroke. 2003;34(8):e138–140. doi: 10.1161/01.STR.0000080935.01264.91
   PubMed Web of Science ®Google Scholar
• Coull AJ, Lovett JK, Rothwell PM. Population-based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004;328(7435):326. doi: 10.1136/bmj.37991.635266.44
   PubMedGoogle Scholar
• Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6(12):1063–1072. doi: 10.1016/S1474-4422(07)70274-0
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007;370(9596):1432–1442. doi: 10.1016/S0140-6736(07)61448-2
   PubMed Web of Science ®Google Scholar
• Lavallée PC, Meseguer E, Abboud H, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 2007;6(11):953–960. doi: 10.1016/S1474-4422(07)70248-X
   PubMed Web of Science ®Google Scholar
• Amarenco P, Lavallée PC, Labreuche J, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016;374(16):1533–1542. doi: 10.1056/NEJMoa1412981
   PubMed Web of Science ®Google Scholar
• Amarenco P, Lavallée PC, Monteiro Tavares L, et al. Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med. 2018;378(23):2182–2190. doi: 10.1056/NEJMoa1802712
   PubMed Web of Science ®Google Scholar
• Lavallée P, Amarenco P. Stroke subtypes and interventional studies for transient ischemic attack. Front Neurol Neurosci. 2014;33:135–146.
   PubMedGoogle Scholar
• Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11–19. doi: 10.1056/NEJMoa1215340
   PubMed Web of Science ®Google Scholar
• Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215–225. doi: 10.1056/NEJMoa1800410
   PubMed Web of Science ®Google Scholar
• Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart association/American stroke association. Stroke. 2014;45(7):2160–2236. doi: 10.1161/STR.0000000000000024
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Chronic Conditions. National Institute for Health and clinical Excellence: guidance. stroke: national clinical guideline for diagnosis and Initial Management of acute stroke and transient ischaemic attack (TIA). London: Royal College of Physicians (UK); 2008. Copyright © 2008, Royal College of Physicians of London.
   Google Scholar
• Jing J, Meng X, Zhao X, et al. Dual antiplatelet therapy in transient ischemic attack and minor stroke with different infarction patterns: subgroup analysis of the CHANCE randomized clinical trial. JAMA Neurol. 2018;75(6):711–719. doi: 10.1001/jamaneurol.2018.0247
   PubMed Web of Science ®Google Scholar
• Li J, Wang A, Zhao X, et al. High-sensitive C-reactive protein and dual antiplatelet in intracranial arterial stenosis. Neurology. 2018;90(6):e447–e454. doi: 10.1212/WNL.0000000000004928
   PubMed Web of Science ®Google Scholar
• Diener HC, Ringleb PA, Savi P. Clopidogrel for the secondary prevention of stroke. Expert Opin Pharmacother. 2005;6(5):755–764. doi: 10.1517/14656566.6.5.755
   PubMed Web of Science ®Google Scholar
• Kernan WN, Viscoli CM, Brass LM, et al. The stroke prognosis instrument II (SPI-II): a clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke. 2000;31(2):456–462. doi: 10.1161/01.STR.31.2.456
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Giles MF, Flossmann E, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366(9479):29–36. doi: 10.1016/S0140-6736(05)66702-5
   PubMed Web of Science ®Google Scholar
• Weimar C, Diener HC, Alberts MJ, et al. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of atherothrombosis for continued Health (REACH) registry. Stroke. 2009;40(2):350–354. doi: 10.1161/STROKEAHA.108.521419
   PubMed Web of Science ®Google Scholar
• Meng X, Wang Y, Zhao X, et al. Validation of the Essen stroke risk score and the stroke prognosis instrument II in Chinese patients. Stroke. 2011;42(12):3619–3620. doi: 10.1161/STROKEAHA.111.624148
   PubMed Web of Science ®Google Scholar
• Maier IL, Bauerle M, Kermer P, et al. Risk prediction of very early recurrence, death, and progression after acute ischaemic stroke. Eur J Neurol. 2013;20(4):599–604. doi: 10.1111/ene.12037
   PubMed Web of Science ®Google Scholar
• Andersen SD, Gorst-Rasmussen A, Lip GY, et al. Recurrent stroke: the value of the CHA2DS2VASc score and the Essen stroke risk score in a nationwide stroke cohort. Stroke. 2015;46(9):2491–2497. doi: 10.1161/STROKEAHA.115.009912
   PubMed Web of Science ®Google Scholar
• Ay H, Gungor L, Arsava EM, et al. A score to predict early risk of recurrence after ischemic stroke. Neurology. 2010;74(2):128–135. doi: 10.1212/WNL.0b013e3181ca9cff
   PubMed Web of Science ®Google Scholar
• Kelly PJ, Albers GW, Chatzikonstantinou A, et al. Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies. Lancet Neurol. 2016;15(12):1238–1247. doi: 10.1016/S1474-4422(16)30236-8
   PubMed Web of Science ®Google Scholar
• Yaghi S, Rostanski SK, Boehme AK, et al. Imaging parameters and recurrent cerebrovascular events in patients with minor stroke or transient ischemic attack. JAMA Neurol. 2016;73(5):572–578. doi: 10.1001/jamaneurol.2015.4906
   PubMed Web of Science ®Google Scholar
• Coutts SB, Moreau F, Asdaghi N, et al. Rate and prognosis of brain ischemia in patients with lower-risk transient or persistent minor neurologic events. JAMA Neurol. 2019;76(12):1439–1445. doi: 10.1001/jamaneurol.2019.3063
   PubMed Web of Science ®Google Scholar
• Wang Y, Johnston SC. Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. Am Heart J. 2010;160(3):380–386.e1. doi: 10.1016/j.ahj.2010.05.017
   PubMed Web of Science ®Google Scholar
• Wang Y, Pan Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-year outcomes. Circulation. 2015;132(1):40–46. doi: 10.1161/CIRCULATIONAHA.114.014791
   PubMed Web of Science ®Google Scholar
• Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352(13):1305–1316. doi: 10.1056/NEJMoa043033
   PubMed Web of Science ®Google Scholar
• Diener H-C. Modified-release dipyridamole combined with aspirin for secondary stroke prevention. Aging Health. 2005;1(1):19–26. doi: 10.2217/1745509X.1.1.19
   Google Scholar
• Coutts SB, Eliasziw M, Hill MD, et al. An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. Int J Stroke. 2008;3(1):3–10. doi: 10.1111/j.1747-4949.2008.00182.x
   PubMed Web of Science ®Google Scholar
• Engelter ST, Amort M, Jax F, et al. Optimizing the risk estimation after a transient ischaemic attack - the ABCDE⊕ score. Eur J Neurol. 2012;19(1):55–61. doi: 10.1111/j.1468-1331.2011.03428.x
   PubMed Web of Science ®Google Scholar
• Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart association/American stroke association. Stroke. 2011;42(1):227–276. doi: 10.1161/STR.0b013e3181f7d043
   PubMed Web of Science ®Google Scholar
• Hurford R, Wolters FJ, Li L, et al. Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study. Lancet Neurol. 2020;19(5):413–421. doi: 10.1016/S1474-4422(20)30079-X
   PubMed Web of Science ®Google Scholar
• Ois A, Gomis M, Rodríguez-Campello A, et al. Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke. Stroke. 2008;39(6):1717–1721. doi: 10.1161/STROKEAHA.107.505438
   PubMed Web of Science ®Google Scholar
• Liu L, Wong KS, Leng X, et al. Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE. Neurology. 2015;85(13):1154–1162. doi: 10.1212/WNL.0000000000001972
   PubMed Web of Science ®Google Scholar
• Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993–1003. doi: 10.1056/NEJMoa1105335
   PubMed Web of Science ®Google Scholar
• Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015;313(12):1240–1248. doi: 10.1001/jama.2015.1693
   PubMed Web of Science ®Google Scholar
• Skajaa N, Adelborg K, Horváth-Puhó E, et al. Risks of stroke recurrence and mortality after first and recurrent strokes in Denmark: a nationwide Registry study. Neurology. 2021;98(4):e329–e342. doi: 10.1212/WNL.0000000000013118
   Web of Science ®Google Scholar
• Xu J, Wang A, Wangqin R. Efficacy of clopidogrel for stroke depends on CYP2C19 genotype and risk profile. Ann Neurol. 2019;86:419–426.
   PubMed Web of Science ®Google Scholar
• Arsava EM, Furie KL, Schwamm LH, et al. Prediction of early stroke risk in transient symptoms with infarction: relevance to the new tissue-based definition. Stroke. 2011;42(8):2186–2190. doi: 10.1161/STROKEAHA.110.604280
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Aday AW, Rose LM, et al. Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy. Circulation. 2018;138(2):141–149. doi: 10.1161/CIRCULATIONAHA.118.034645
   PubMed Web of Science ®Google Scholar
• McCabe JJ, Walsh C, Gorey S, et al. C-Reactive protein, interleukin-6, and vascular recurrence after stroke: an Individual Participant data meta-analysis. Stroke. 2023;54(5):1289–1299. doi: 10.1161/STROKEAHA.122.040529
   PubMed Web of Science ®Google Scholar
• Kleindorfer DO, Towfighi A, Chaturvedi S, et al. Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart association/American stroke association. Stroke. 2021;52(7):e364–e467. doi: 10.1161/STR.0000000000000375
   PubMed Web of Science ®Google Scholar
• Ohara M, Yoshimoto T, Okazaki S, et al. RNF213 p.R4810K variant carriers with intracranial arterial stenosis have a low Atherosclerotic Burden. J Atheroscler Thromb. 2022;29(11):1655–1662. doi: 10.5551/jat.63379
   PubMed Web of Science ®Google Scholar
• Zhou H, Jing J, Pu Y, et al. Detailed phenotype of RNF213 p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack. Stroke Vasc Neurol 2023; svn-2022–002276.
   Google Scholar
• Gorelick PB, Wong KS, Bae HJ. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008;39:2396–2399.
   PubMed Web of Science ®Google Scholar
• Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013;12(11):1106–1114. doi: 10.1016/S1474-4422(13)70195-9
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao X, Liu L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese intracranial atherosclerosis (CICAS) study. Stroke. 2014;45(3):663–669. doi: 10.1161/STROKEAHA.113.003508
   PubMed Web of Science ®Google Scholar
• Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995;26(1):14–20. doi: 10.1161/01.STR.26.1.14
   PubMed Web of Science ®Google Scholar